Preliminary Draft for
Societal Impact of Pain
SIP Symposium 2014
Interactive Panel Discussions
5th European Annual Event
European Parliament
Brussels
60 rue Wiertz /
Wiertzstraat 60,
Room to be announced
November 18th 2014
SIP Symposium 2014 – Interactive Panel Discussions
Pain therapy and palliative care will be listed as healthcare priorities during the Italian presidency of the EU council in the second semester of 2014.This is exciting because for the first time ever all EU Ministers of Health will be called upon to discuss how to direct national and European strategies and health policies to address the need for improved pain care in Europe.
Considering the importance of this announcement it was also decided to celebrate the 5th SIP symposium by inviting Nick Ross, widely regarded as one of the most professional conference moderators in the world. The intention is to break away completely from the traditional format by invited leading European stakeholders to join a series of provocative and audience interactive panel discussions and interviews. The aim will be to define what needs to be done now to ensure that chronic pain and palliative care will receive the priority on the agenda of the EU institutions and the member states also in the long term.
Aims of the SIP Platform
The European, multi-stakeholder platform Societal Impact of Pain (SIP) was created in 2010 as a joint initiative of the European Pain Federation EFIC® and the pharmaceutical company Grünenthal GmbH. The aims are to
- raise awareness of the relevance of the impact that pain has on our societies, health and economic systems;
- exchange information and share best-practices across all member states of the European Union;
- develop and foster European-wide policy strategies & activities for an improved pain care in Europe.
As a multi-stakeholder platform SIP provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, insurances, representatives of health authorities, regulators and budget holders. The scientific framework of the SIP platform thereby is under the responsibility of EFIC®. Grünenthal is responsible for funding and non-financial support (e.g. logistical support).
Endorsement of the SIP Platform
As in the past we anticipate endorsement of the event by the EU council and > 180 international organisations. Here the link to a list of our endorsers.
Registration
Deadline for registration is September 30th – 2014 Please register your participation via this link https://www.regonline.com/sip2014
Contact numbers
EFIC Office: secretary@efic.org or +32 (2) 251 55 10
Preliminary programme
Tuesday 18th of November
Simultaneous translation will be provided in Italian, Spanish, French, German, English
8:45 | Meet at the Spinelli entrance of the European Parliament, 60 rue Wiertz ( towards Place Luxembourg ) to collect your entry badge.
Please note all delegates will be accompanied to the meeting room in the parliament and that in the registration process the following information has to be provided in order to obtain the entry badges for the European Parliament : date of birth, ID or passport number and nationality
|
9:30 | Opening and Welcome |
9:35 | Panel Discussion 1 : Out of sight, out of mind – why the reluctance to see pain as a critical issue
Panelists: -To be announced
Aims
|
10:30 -11:00 | Refreshment break |
11:00-12:00 | Panel Discussion 2: Good Practise –how do we stimulate innovation and accelerate the replication
Panelists: -To be announced
Aims
|
12:00-13:00 | Lunch – EU Parliament |
13:00-14:00 | Panel Discussion 3: Declaration of the Italian Presidency* on Pain and Palliative Care What now
Panelists: – To be announced – Italian minister of Health to be confirmed – Senior delegates from other ministries of health to be confirmed
Aims:
*Confirmation from the Italian Presidency that a declaration on pain therapy and palliative care will follow the informal health council meeting on 22nd and 23rd of September is awaited.
|
14:00-14:30 | Refreshment break |
14:30- 15:30 | Panel Discussion 4: The future – How can stakeholders advocating for the recognition of pain in Europe work together to ensure change
Panelists: -To be announced
Aims
|
15:30 | Closing remarks : Prof Chris Wells , President EFIC |
16:00 | Departure |
Faculty :
The experts below have already confirmed their participation as panellists. Confirmation about the participation of the EU institutions will take place after the start of the new term for elected and appointed officials
- Chris Wells: President of the European Pain Federation EFIC®
- Hans Kress: Immediate Past President of the European Pain Federation EFIC®
- Bart Morlion: President-Elect of the European Pain Federation EFIC®
- Giustino Varrassi: EU liaison officer and Past President of the European Pain Federation EFIC®
- Minister of Health: Italy to be confirmed
- Willem Scholten: Consultant – Medicines and Controlled Substances and formerly with the WHO Access to Controlled Medicines
- Robert Johnstone: Board member of the International Alliance of Patients
- Günter Danner: Deputy Director Liaison Bureau of the German Social Security institutions
- Audrey Craven: President of the European Federation of Neurological Associations
- Ceri Philips: Professor of Health Economics and Head of the Institute for Health Research
- Rolf-Detlef Treede: President-Elect of the International Association for the Study of Pain
- Neil Betteridge: Vice Chair of the Chronic Pain Policy Coalition
- David Hughes, Professor of Health Economics, University of Chester
- Das Meherzin: Consultant Clinical Psychologist and clinical lead of Dorset Community Pain Service
- Ernst Daniel Smid: Founder of Stichting Pijn Bij Kanker
- Invitation process ongoing
About SIP
The “Societal Impact of Pain” platform (SIP) is an international platform created in 2010 as a joint initiative of EFIC and the pharmaceutical Grünenthal GmbH and aims for 1) raising awareness of the relevance of the impact that pain has on our societies, health and economic systems 2) exchanging information and sharing best-practices across all member states of the European Union 3) developing and fostering European-wide policy strategies & activities for an improved
pain care in Europe (Pain Policy).The platform provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, insurances, representatives of health authorities, regulators and budget holders.
The scientific framework of SIP is under the responsibility of the European Pain Federation EFIC® . The pharmaceutical company Grünenthal GmbH is responsible for funding and non-financial support (e.g. logistical support).The scientific aims of the SIP symposia have been endorsed by a large number of international and national pain advocacy groups, scientific organisations and authorities.
More information: http://www.sip-platform.eu/
Background about past SIP events
In the past four years EFIC® and Grünenthal have organized four European scientific symposia on the societal impact of chronic pain in Europe: The first symposium SIP 2010 established the multi-stakeholder network and thus a platform for sharing best practices of pain management throughout Europe.
The second symposium SIP 2011 took place in the European Parliament and was supported by all three European institutions: Members of the EU Parliament, the EU Commissioner for Health & Consumer Policy, as well as the Hungarian Presidency holding the EU Presidency from Jan-Jun 2011. Furthermore, it was endorsed by more than 85 international and national patient advocacy groups, scientific organisations and health authorities. Key result from SIP 2011 was the SIP Road Map for Action outlining seven policy dimensions on how the EU institutions and member states can effectively address the societal impact of pain at EU level.
The third symposium SIP 2012 took place in Copenhagen, Denmark. More than 400 stakeholders from more than 30 countries participated in the meeting, which was officially held under the high patronage of the Italian Prime Minister and the Italian Ministry of Health and Welfare, and which was endorsed by more than 161 organisations. For the first time concrete national policies on pain management were shared with the participants reflecting how EU Member States succeeded to implement the SIP Road Map for Action on national level.
In 2013 the programme committee hosted the SIP Focus Groups in Brussels, endorsed by > 180 organisations. The focus groups concentrated on two concrete policy topics linked to the SIP Road Map for Action. The first focus group served as an initial face-to-face event for a group of European experts that aims to develop “Recommendations for a European set of quality indicators for chronic non-malignant pain management”. The project is ongoing and EFIC has appointed a dedicated taskforce to deal with this important topic. The second focus group hosted in the European Parliament served as an opportunity for sharing best practices and exchanging models among EU Member States for keeping our workforce healthy. A “Proposal for Action”, giving national examples of rehabilitation and integrated care programs and proposals for concrete measures on EU policy level was developed and several of the best practice examples presented are now formally included in the compilation of good practice examples published by the European Commission as part of the European Innovation Partnership on Active and Healthy Aging.
About European Pain Federation EFIC®
The European Pain Federation EFIC® is a multidisciplinary professional organisation in the field of pain research and medicine, consisting of the 36 chapters of the International Association for the Study of Pain (IASP®), which are the IASP approved official National Pain Societies in each country. Established in 1993, EFIC’s constituent chapters represent Pain Societies from 36 European countries and close to 20,000 physicians, basic researchers, nurses, physiotherapists, psychologists and other healthcare professionals across Europe, who are involved in pain management and pain research.
More information: http://www.efic.org/
About Grünenthal
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation.
More information: http://www.grunenthal.com
USEFUL LINKS
Societal Impact of Pain – website of the SIP platform with in-depth content and news
The European Pain Federation EFIC® – website with details on EFIC® activities and chapters
Nick Ross – conference moderator